CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin


25 March 2015

Should the FDA revoke approvals for non-abuse deterrent generic opioids?

Scientist and Product Specialist Linda Hermans explores whether the FDA should revoke approvals for non-abuse deterrent generic opioids.

24 March 2015

Pharmacy scheme raises dementia diagnosis rates

A small-scale evaluation project has demonstrated the value of using in-pharmacy Cantab Mobile assessments to help identify patients that might otherwise be missed.

24 March 2015

Early dementia diagnosis gives patients more options

Doncaster CCG improve dementia diagnosis rates through the use of Cantab Mobile.

13 March 2015

Characterization Of Cognitive Decline Over 5 Years in an Incident Parkinson’s Disease Cohort

Pradeep Nathan, PhD, Senior Scientific Director presented a poster at ADPD 2015 on the Characterization Of Cognitive Decline Over 5 Years in an Incident Parkinson’s Disease Cohort, view the poster here.

12 March 2015

The use of CANTAB and language tests in healthy and pathological aging

'CANTAB and language tests to search for the limits between normal and pathological aging' was recently inducted into the Cantab Bibliography, corresponding author Cristovam W Picanço Diniz explains more about the research study. 

11 March 2015

The benefits of language and culture independent touchscreen cognitive tests

When assessing cognitive function, tests that are reliable, time and cost efficient and are comparable across cultures and languages are the key to producing accurate and valid results. There are various cognitive assessment tools out there, but what are the benefits of using language and culture independent touchscreen tests such as CANTAB?

web-based testing, wearables, voice recognition, voice, virtual clinical trials, technology, swm, subjective measures, social cognition, smartphones, schizophrenia research, schizophrenia, safety, research funding, research, remote testing, rare disease, psychosis, prodromal, pro-cognitive, press release, presenteeism, precision psychiatry, pre-clinical, poster, personalised medicine, patient-centric, patient recruitment, patient engagement, parkinson's disease, pal, paired associates learning, ots, occupational health, objective measures, neurotech, neuroscience, near-patient testing, multiple sclerosis, ms, mental wellbeing, mental health at work, mental health, mdd, mci, major depression, machine learning, longitudinal, ied, hot cognition, high-frequency testing, healthcare, guide, funding, fatigue, ert, epidemiology, emotion recognition, ecoa, ebt, ebbinghaus, early career researchers, early alzheimer's disease, digital tools, digital health, depression, dementia, covid-19, cognitive wellbeing, cognitive testing, cognitive science, cognitive safety, cognitive research, cognitive load, cognitive impairment, cognitive function, cognitive dysfunction, cognitive deficits, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, chronic illness, chronic health conditions, cantab testimonial, cantab research grant, cantab for clinical trials, cantab, brain health, biomarkers, automatic speech recognition, attention, alzheimer's disease, affective cognition, adolescents, absenteeism,